Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA0701 Inhibitors

KIAA0701 inhibitors represent a class of chemical compounds designed to modulate the activity of the KIAA0701 protein, a protein that plays a crucial role in various cellular processes. KIAA0701 is associated with DNA damage repair, transcriptional regulation, and chromatin remodeling. By inhibiting the activity of KIAA0701, these inhibitors can alter the dynamics of gene expression and DNA repair pathways, potentially influencing cellular growth and differentiation. Structurally, KIAA0701 inhibitors are often characterized by a high affinity for the active or binding domains of the protein, making them specific in their action. These compounds often employ mechanisms that can disrupt the interaction of KIAA0701 with other proteins or DNA, leading to changes in the protein's function at the molecular level.

KIAA0701 inhibitors are of interest due to their ability to modulate cellular responses to stress and genomic instability. By targeting specific regions of KIAA0701, they can prevent the activation of certain pathways involved in the maintenance of genomic integrity. This disruption can impact the regulation of gene expression, particularly in response to damage signals. Additionally, research into KIAA0701 inhibitors focuses on optimizing their selectivity and minimizing off-target effects, ensuring that their activity is confined to the intended protein pathways. These inhibitors can be synthesized through various chemical processes, and ongoing studies often explore their structure-activity relationships to better understand how modifications to their chemical structures can enhance their potency or specificity.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Inhibits cyclin-dependent kinases (CDKs) which are involved in the phosphorylation of UHRF1BP1L, thus reducing its activity.

Olomoucine

101622-51-9sc-3509
sc-3509A
5 mg
25 mg
$72.00
$274.00
12
(1)

Targets CDKs that regulate the cell cycle and phosphorylation status of UHRF1BP1L, leading to its functional inhibition.

Purvalanol A

212844-53-6sc-224244
sc-224244A
1 mg
5 mg
$72.00
$297.00
4
(2)

Selectively inhibits CDKs and therefore decreases phosphorylation-dependent functions of UHRF1BP1L.

Indirubin-3′-monoxime

160807-49-8sc-202660
sc-202660A
sc-202660B
1 mg
5 mg
50 mg
$79.00
$321.00
$671.00
1
(1)

CDK inhibitor that would prevent phosphorylation and subsequent activation of UHRF1BP1L.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

A potent CDK inhibitor which would impede the phosphorylation cycle necessary for UHRF1BP1L function.

5-Iodotubercidin

24386-93-4sc-3531
sc-3531A
1 mg
5 mg
$153.00
$464.00
20
(2)

Inhibits adenosine kinase which could decrease phosphorylation levels indirectly affecting UHRF1BP1L activity.

VX 745

209410-46-8sc-361401
sc-361401A
10 mg
50 mg
$183.00
$842.00
4
(1)

P38 MAP kinase inhibitor that may reduce UHRF1BP1L activity by altering stress response signaling pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Another p38 MAP kinase inhibitor that could decrease the phosphorylation of UHRF1BP1L through stress pathway inhibition.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, which is involved in signaling pathways that may phosphorylate and thereby regulate UHRF1BP1L.

Doramapimod

285983-48-4sc-300502
sc-300502A
sc-300502B
25 mg
50 mg
100 mg
$149.00
$281.00
$459.00
2
(1)

This p38 MAPK inhibitor could diminish the phosphorylation and activity of UHRF1BP1L by altering the MAPK pathway.